Correction to: Comparison of darbepoetin alpha and recombinant human erythropoietin for treatment of anemia in pediatric chronic kidney disease: a non-inferiority trial from India
- PMID: 36264341
- DOI: 10.1007/s00431-022-04669-4
Correction to: Comparison of darbepoetin alpha and recombinant human erythropoietin for treatment of anemia in pediatric chronic kidney disease: a non-inferiority trial from India
Erratum for
-
Comparison of darbepoetin alpha and recombinant human erythropoietin for treatment of anemia in pediatric chronic kidney disease: a non-inferiority trial from India.Eur J Pediatr. 2023 Jan;182(1):101-109. doi: 10.1007/s00431-022-04650-1. Epub 2022 Oct 11. Eur J Pediatr. 2023. PMID: 36220980 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
